Web Extra—Fast Fire: Human Genome
While the "Fast Money" traders are always fast, they're not always right.
Take Guy Adami of Drakon Capital, for example, who on Sept. 7 recommended Human Genome . Since then, the stock has fell by 16 percent. The biotech space has hit some bumps, but Adami is sticking with his call on a long-term basis because he thinks it will go higher.
Watch the video to see his full explaination.
This content is only available online - you won't find these trades on TV.
Got something to to say? Send us an e-mail at email@example.com and your comment might be posted on the Rapid Recap. If you'd prefer to make a comment but not have it published on our website send those e-mails to firstname.lastname@example.org.
CNBC.com with wires